Small Molecule Degraders of CBP/p300 Proteins
Abstract:
The present disclosure relates to compounds of Formula (I), and the pharmaceutically


A—(CH2)m—X—Y—Z—B1  I,

acceptable salts and solvates thereof, wherein A, m, X, Y, Z, and B1 are as defined as set forth in the specification. The present disclosure also relates to uses of the compounds, e.g., in treating or preventing a condition or disorder responsive to the degradation of CBP/P300 proteins (e.g., cancer).
Information query
Patent Agency Ranking
0/0